THE9 LTD-ADR (NCTY) Fundamental Analysis & Valuation

NASDAQ:NCTY • US88337K4013

Current stock price

5.11 USD
-0.09 (-1.73%)
Last:

This NCTY fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. NCTY Profitability Analysis

1.1 Basic Checks

  • NCTY had negative earnings in the past year.
  • The reported net income has been mixed in the past 5 years: NCTY reported negative net income in multiple years.
  • NCTY had a negative operating cash flow in each of the past 5 years.
NCTY Yearly Net Income VS EBIT VS OCF VS FCFNCTY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M -600M -800M

1.2 Ratios

  • NCTY's Return On Assets of -19.98% is on the low side compared to the rest of the industry. NCTY is outperformed by 72.73% of its industry peers.
  • NCTY's Return On Equity of -29.69% is on the low side compared to the rest of the industry. NCTY is outperformed by 65.09% of its industry peers.
Industry RankSector Rank
ROA -19.98%
ROE -29.69%
ROIC N/A
ROA(3y)-56.25%
ROA(5y)123.9%
ROE(3y)-719.68%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
NCTY Yearly ROA, ROE, ROICNCTY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 -500 -1K -1.5K -2K

1.3 Margins

  • NCTY does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
NCTY Yearly Profit, Operating, Gross MarginsNCTY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20K -20K 40K -40K 60K -60K

2

2. NCTY Health Analysis

2.1 Basic Checks

  • NCTY does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, NCTY has more shares outstanding
  • Compared to 5 years ago, NCTY has more shares outstanding
  • Compared to 1 year ago, NCTY has a worse debt to assets ratio.
NCTY Yearly Shares OutstandingNCTY Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
NCTY Yearly Total Debt VS Total AssetsNCTY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

  • Based on the Altman-Z score of -8.48, we must say that NCTY is in the distress zone and has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of -8.48, NCTY is doing worse than 88.73% of the companies in the same industry.
  • A Debt/Equity ratio of 0.30 indicates that NCTY is not too dependend on debt financing.
  • The Debt to Equity ratio of NCTY (0.30) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF N/A
Altman-Z -8.48
ROIC/WACCN/A
WACC5.43%
NCTY Yearly LT Debt VS Equity VS FCFNCTY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M

2.3 Liquidity

  • A Current Ratio of 1.54 indicates that NCTY should not have too much problems paying its short term obligations.
  • NCTY has a Current ratio (1.54) which is comparable to the rest of the industry.
  • NCTY has a Quick Ratio of 1.54. This is a normal value and indicates that NCTY is financially healthy and should not expect problems in meeting its short term obligations.
  • NCTY has a Quick ratio (1.54) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.54
Quick Ratio 1.54
NCTY Yearly Current Assets VS Current LiabilitesNCTY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2

3. NCTY Growth Analysis

3.1 Past

  • The earnings per share for NCTY have decreased strongly by -135.25% in the last year.
  • The Revenue for NCTY has decreased by -53.07% in the past year. This is quite bad
  • The Revenue has been growing by 226.74% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-135.25%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-20150%
Revenue 1Y (TTM)-53.07%
Revenue growth 3Y-6.32%
Revenue growth 5Y226.74%
Sales Q2Q%-32.6%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NCTY Yearly Revenue VS EstimatesNCTY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

0

4. NCTY Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for NCTY. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NCTY Price Earnings VS Forward Price EarningsNCTY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NCTY Per share dataNCTY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. NCTY Dividend Analysis

5.1 Amount

  • No dividends for NCTY!.
Industry RankSector Rank
Dividend Yield 0%

NCTY Fundamentals: All Metrics, Ratios and Statistics

THE9 LTD-ADR

NASDAQ:NCTY (4/10/2026, 8:00:01 PM)

5.11

-0.09 (-1.73%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners0.44%
Inst Owner Change0%
Ins Owners2.55%
Ins Owner Change0%
Market Cap45.92M
Revenue(TTM)81.69M
Net Income(TTM)-142.55M
Analysts0
Price TargetN/A
Short Float %49.66%
Short Ratio4.31
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.84
P/FCF N/A
P/OCF N/A
P/B 0.65
P/tB 0.67
EV/EBITDA N/A
EPS(TTM)-2.47
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS1.33
BVpS7.82
TBVpS7.67
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -19.98%
ROE -29.69%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-56.25%
ROA(5y)123.9%
ROE(3y)-719.68%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.11
Health
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.54
Quick Ratio 1.54
Altman-Z -8.48
F-ScoreN/A
WACC5.43%
ROIC/WACCN/A
Cap/Depr(3y)98.18%
Cap/Depr(5y)117.73%
Cap/Sales(3y)74.19%
Cap/Sales(5y)71.38%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-135.25%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-20150%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-53.07%
Revenue growth 3Y-6.32%
Revenue growth 5Y226.74%
Sales Q2Q%-32.6%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-17.09%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-9.84%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y4.58%
OCF growth 3YN/A
OCF growth 5YN/A

THE9 LTD-ADR / NCTY Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for THE9 LTD-ADR?

ChartMill assigns a fundamental rating of 1 / 10 to NCTY.


Can you provide the valuation status for THE9 LTD-ADR?

ChartMill assigns a valuation rating of 0 / 10 to THE9 LTD-ADR (NCTY). This can be considered as Overvalued.


Can you provide the profitability details for THE9 LTD-ADR?

THE9 LTD-ADR (NCTY) has a profitability rating of 0 / 10.


What is the financial health of THE9 LTD-ADR (NCTY) stock?

The financial health rating of THE9 LTD-ADR (NCTY) is 2 / 10.


Is the dividend of THE9 LTD-ADR sustainable?

The dividend rating of THE9 LTD-ADR (NCTY) is 0 / 10 and the dividend payout ratio is 0%.